One study, published by Ip et al., demonstrated that patients with low serum MBL levels were at higher risk of becoming infected with SARS-CoV, suggesting that complement activation via MBL may be critical in protecting the host from SARS-CoV infection [5]. Here, MBL2 is linked to severe acute respiratory syndrome.